How will you translate your next big idea? Fancy hearing what the UK’s top biomedical funders are looking for and informally discussing your ideas?

On 12th May, the University of Birmingham is holding its second Translational Funding Event. We have had confirmation that representatives from BBSRC, CRUK, EPSRC, MRC and Wellcome Trust will attend and each give a brief presentation on how to submit a successful application to their translational funding schemes.  We also hope to welcome ARUK, LLR and NIHR.  There will be an informal networking lunch, and the opportunity to book a 1-2-1 slot (10-15 mins) to discuss your research and the suitability of it to a particular funder. Continue reading


CRUK calls on non-cancer immunologists to apply for the Cancer Immunology Project Awards

These exciting awards support work building on  understanding of the role of the immune system in cancer.  They provide 3 years of funding, that can be used to fund scientific posts and associated running costs.

The Awards encourage immunologists from outside the field of cancer to apply their research to the disease.  This area of research is already leading to new treatments.

Deadline for final submission 18 May 2015.

Find more information at

CRUK Event 18th September

Cancer Research UK have outlined their CRUK Research Strategy and are launching this strategy along with new funding streams at a series of events at key centres around the UK.  A key element of their new strategy is multi-disciplinary research and this is reflected in their recent call for multi-disciplinary research proposals.

The Birmingham CRUK Research Strategy Event  will be on the 18th September 2014; CRUK Research Strategy Event Birmingham. The event is hoped to encourage cross-discipline cancer research in Birmingham.

The meeting will be held in the Seminar Room, S104, in the School of Cancer Sciences on Vincent Drive.

CRUK Multidisciplinary Project Award

CRUK Multidisciplinary Project Award

Currently open

These awards fund individual project proposals for collaborations between cancer researchers and scientists from engineering/physical science disciplines. Funding is for 4 years and can be worth up to £500k.  There is no co-location requirement. Continue reading

Translational fun(ding) day

Thank you to everyone who came along to the recent translational funding event, where we had speakers from BBSRC, BHF, CRUK, MRC and The Wellcome Trust.  Feedback has been very positive, both from the academics and the funders involved.

We will be arranging similar networking opportunities in the future and would like to hear which funders you are interested in meeting.  Presentations from the day can be requested from your Tech Transfer Officer, Claire Fenlon (

CRUK Visit

Kelly Sheehan-Rooney, Grant Manager at Cancer Research UK, visited the College of MDS last week to speak to researchers about research opportunities. She outlined the principles of writing a good application and summarised the CRUK awards available for early and mid-career researchers. In particular Kelly discussed the new Programme Foundation Award scheme recently launched.

If you would like a copy of the presentation slides, please email us at RKToffice[at]

Translational Funding Event – Thursday 10th July

Unlock the translational potential of your research

On Thursday 10th July, the College of Medical & Dental Sciences are hosting a Translational Funding Event to raise awareness around what translational funding is available, which may appropriate for you, and at what stage you should be considering external translational funding schemes. Continue reading

Stand Up To Cancer

CRUK have announced a new funding opportunity in partnership with Stand Up To Cancer (SU2C) – the SU2C-CRUK Translational Research Fellowship. The American Association for Cancer Research (AACR) is now accepting applications from exceptional post-doctoral (clinical and non-clinical) researchers who are focused on accelerating progress in translational research. This transatlantic scheme will provide up to four years’ support to UK- and US-based researchers. Continue reading